Company attributes
Industry
Location
B2X
Pitchbook URL
Number of Employees (Ranges)
51 – 200
Email Address
hr@forgebiologics.com0
media@forgebiologics.com0
hello@forgebiologics.com0
bd@forgebiologics.com0
Number of Employees
142
Full Address
Columbus, Ohio, US
Investors
Founded Date
2020
Total Funding Amount (USD)
160,000,000
Latest Funding Round Date
April 29, 2021
Competitors
Latest Funding Type
Country
Other attributes
Company Operating Status
Active
Public/Private
Private
Forge Biologics, based in Grove City, Ohio, manufactures gene therapies for rare diseases. It is primarily focused on a gene therapy solution for Krabb Disease, described as a "pediatric leukodystrophy affecting about 1 in 100,000 people in the U.S."
The company is developed FBX-101 to treat Krabb disease. It has been shown to "dramatically improve the lifespan of trated animals."
Forge Biologics plans to build a 175,000 sq. ft office and production facility that is cGMP compliant in the E.U. and U.S.
Timeline
No Timeline data yet.
Funding Rounds
Products
Acquisitions
SBIR/STTR Awards
Patents
Further Resources
No Further Resources data yet.
